Lavipharm SA
ATHEX:LAVI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lavipharm SA
ATHEX:LAVI
|
GR |
|
Prospect Resources Ltd
ASX:PSC
|
AU |
|
Waterstone Financial Inc
NASDAQ:WSBF
|
US |
|
A
|
Accuray Inc
F:XEJ
|
US |
|
Japan Post Holdings Co Ltd
OTC:JPHLF
|
JP |
|
B
|
Buru Energy Ltd
F:BUD
|
AU |
|
C
|
China High Speed Transmission Equipment Group Co Ltd
XMUN:BGR
|
KY |
|
Cool Technologies Inc
OTC:WARM
|
US |
|
C
|
Chorus Ltd
F:7CH
|
NZ |
|
S
|
Scor SE
DUS:SDRC
|
FR |
|
R
|
Revvity Inc
F:PKN
|
US |
Intrinsic Value
Is LAVI undervalued or overvalued?
See the intrinsic value estimate for Lavipharm SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
LAVI looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with LAVI’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Lavipharm Does
Lavipharm SA is a Greek pharmaceutical company that develops, makes, and sells medicines and health products. Its portfolio includes prescription drugs, over-the-counter remedies, and transdermal patches that deliver medicine through the skin. It also works with other drug companies through manufacturing, licensing, and distribution arrangements.
- Headquarters
- Greece GR
- Employees
- 285
- IPO date
- Nov 8, 1995
Earnings Waterfall
Lavipharm SA
The intrinsic value for Lavipharm SA (LAVI) under the Base Case is hidden EUR.
Compared with the current market price of 1.518 EUR, the stock appears hidden.